Download David James Farabee - UCLA Integrated Substance Abuse Programs

David James Farabee
Curriculum Vitae
PERSONAL HISTORY
Home Address: 24721 Laurel Ridge Drive
Malibu, California 90265
Home Phone:
310.963.0009
Office Address: UCLA Integrated Substance Abuse Programs
University of California, Los Angeles
11075 Santa Monica Blvd, Suite 200
Los Angeles, California 90025
Office Phone:
310.267.5535
E-mail:
[email protected]
Date of Birth:
July 16, 1963; Dallas, Texas
Citizenship:
United States
EDUCATION
1985
University of Texas, Austin
1988
Texas A&M University, Commerce
1992
Texas Christian University
B.A., Psychology
M.S., Psychology
Ph.D., Experimental Psychology
PROFESSIONAL EXPERIENCE
2008-present Professor-in-Residence. UCLA Department of Psychiatry & Biobehavioral
Sciences.
2005-2008 Research Psychologist at the University of California at Los Angeles
Integrated Substance Abuse Programs (ISAP).
2000-2004 Associate Research Psychologist at the University of California at Los
Angeles Integrated Substance Abuse Programs (ISAP).
1997-1999 Assistant Research Psychologist at the University of California at Los
Angeles Integrated Substance Abuse Programs (ISAP).
1995-1997 Assistant Professor of Psychiatry and Research Scientist at the Center on
Drug and Alcohol Research at the University of Kentucky.
1993-1995 Lead Analyst, Texas Commission on Alcohol and Drug Abuse.
1989-1992 Research Assistant, Institute of Behavioral Research, Texas Christian
University.
PROFESSIONAL ACTIVITIES
Professional Memberships
2004-present American Psychological Association
1997-present American Society of Criminolgy
Community Activities
Advisor to the Africa Mental Health Foundation (AMHF) in the area of alcohol and
substance abuse (www.africamentalhealthfoundation.org).
Member of the County of Los Angeles Department of Mental Health Adult Systems of
Care—Jail Mental Services, Quality, Academics and Research Advisory Board.
Member of the U.S. Health and Human Services Advisory Committee on HIV and STD
Prevention of the Centers for Disease Control (2002-2005).
Co-Editor of the Offender Programs Report (New York: Civic Research Institute)
Visiting professor at the Universidad Autonoma de Nuevo Leon in Monterrey, Mexico
(2001-present)
Member of the UCLA Institutional Review Board (2006-2009)
Consulting Activity
2006
Statistical analysis and report preparation (for Northrop Grumman) to
for the national Opioid Treatment Program Accreditation Evaluation,
funded by SAMHSA.
2004-present Evaluator for Dallas site of the CSAT-funded Treatment Capacity
Expansion project.
2001
Conducted a recidivism study comparing public and private prison releases
in the State of Florida, funded by the Florida Correctional Privatization
Commission.
2000
Policy analyst for the Texas Comptroller Office. Provided
recommendations for improving the treatment system operated by the
Texas Department of Criminal Justice.
1999-2001
Statistical analysis and manuscript preparation for Friends Research, Inc.
1996
Evaluated the effectiveness of alternative criminal justice sanctions used in
northern Kentucky. Study funded by the Northern Kentucky Corrections
Advisory Board.
1995
Technical Merit Reviewer for Center for Substance Abuse Treatment RFP:
Criminal Justice Treatment Network. Washington, D.C.
Editorial Services
Reviewer for Addiction, Crime & Delinquency, Criminology and Public Policy, Drug
and Alcohol Dependence, Criminal Justice and Behavior, & Journal of Substance Abuse
Treatment. Editor of the Offender Programs Report.
HONORS
1993-1994
Sigma Xi Research Society, President (University of Texas at Austin
Chapter)
RESEARCH GRANTS RECEIVED
Active
Depot Pharmacotherapies for Opioid-Dependent Offenders: Outcomes and Costs
1 U01 DA034743-01A1 (PI: Farabee)
06/01/13 - 05/31/17
NIH/NIDA
$422,062
04/28/17
2
The major goal of this project is to assess two recently developed depot
pharmacotherapies for opiate dependence—Vivitrol and Probuphine, with regard to
patient acceptance, effectiveness, and economic benefits.
Evaluation of the Integrated Services for Mentally Ill Parolees (ISMIP) and Case
Management Reentry Pilot (CMRP) Programs
Contract No.5600005097 (PI: Farabee)
California Department of Corrections and Rehabilitation 01/01/15-12/31/16 2016
This project involves a process and outcome evaluation of the ISMIP and CMRP
programs. The process evaluation is devoted to describing how these programs actually
function, and to what extent eligible parolees participate in the available services. The
outcome evaluation will focus on arrests, convictions, and time to first arrest for program
referrals compared to matched comparison subjects drawn from concurrent release
samples.
Completed
Enhancing Follow-up Rates Through a Rechargeable Incentive Card (RIC) System
2 R42 DA025387 (PI: Farabee)
05/01/12 - 01/31/14
NIH/NIDA/Calance Corporation
$335,020
The major goal of this Phase II Small Business Technology Transfer (STTR) project is to
conduct a randomized field test of the rechargeable incentive card (RIC) system
developed in Phase I, and to execute a detailed plan to commercialize the finalized set of
products and services for the purpose of improving validity and generalizability of
longitudinal substance abuse research and follow-up rates.
An Experimental Comparison of Telepsychiatry and Conventional Psychiatry for
Mentally Ill Parolees
2010-90983-CA-IJ (PI: Farabee)
10/01/10-06/30/15
National Institute of Justice/U.S. DOJ
$608,248
The major goal of this project is to evaluate the effectiveness of telepsychiatry for
parolees relative to conventional face-to-face sessions. Outcomes include therapeutic
alliance, medication adherence, clinic attendance, psychological functioning, and
recidivism.
It Came from the North: Estimating the Production of Synthetic Drugs in Quebec,
Canada
2010-94019-CA-IJ (PI: Farabee)
01/01/11-12/31/14
National Institute of Justice/U.S. DOJ
$367,845
The major goal of this project is to estimate the size of synthetic drug production
(methamphetamine in particular) in Quebec, Canada, assess its export potential, and
explore implications for counter-narcotics policies.
04/28/17
3
The Pacific Coast Research Center Of the NIDA CJ-DATS
5 U01 DA16211-03 (Co-PI: Farabee)
09/30/02 - 09/01/13
NIH/NIDA
$3,265,000
The major goal of this project is to collaborate with other CJ-DATS Research Centers in
developing and evaluating system-level interventions for drug abusing offenders in
prison and on parole.
Evaluation of the P3Benefits Program
C08.145 (PI: Farabee)
State of California/CDCR
11/1/08—10/31/11
$268,584
In accordance with the California Logic Model, to insure a continuum of care, the
Division of Adult Parole Operations (DAPO) is utilizing contracted benefits social
workers (BSW) within the prisons to apply for federal and state benefit entitlements
prior to an inmate’s return to the community. Benefits that will be applied for are: SSA
benefits, State sponsored Medi-Cal, and VA benefits. In accordance to Provision 22:
Reducing Recidivism, the purpose of this evaluation is to provide CDCR Executive Staff
and the California State Legislature with information about the effectiveness of the P3
Benefits Program.
A Randomized Controlled Trial of the Second Chance Program for Ex-Inmates
2008-7752 (PI: Farabee)
09/01/08 - 09/01/11
Smith Richardson Foundation
$345,435
The major goal of this project was to conduct a process and outcome evaluation and a
cost analysis of the Second Chance’s PREP program.
Four Models of Telephone Support for Stimulant Recovery
1 R01 DA18208 (PI: Farabee)
04/01/05 - 03/31/11
NIH/NIDA
$2,627,680
The major goal of this project wais to compare the efficacy of four low-cost, telephone
support protocols for patients who have completed the intensive phase of a structured,
outpatient stimulant abuse treatment program.
Enhancing Follow-up Rates Through a Rechargeable Incentive Card (RIC)
1 R41 DA025387-01 (Farabee)
07/01/08 - 3/31/11
Calance Corp/NIH/NIDA
$35,097
System
The major goal of this project was to develop a national network that supports a
rechargeable incentive card (RIC) system designed to enhance follow-up rates and to
assess the feasibility and commercial potential of the system.
04/28/17
4
The Utility of the COMPAS in Assessing Needs and Predicting Recidivism
C06.417 (PI: Farabee)
01/01/07 – 12/31/09
State of California/CDC
$300,000
The purpose of this project was to assess the predictive validity of a risk assessment tool
(COMPAS) recently adopted by the California Department of Corrections. Our study
evaluated the extent to which this instrument can correctly classify offenders who pose
the greatest risks upon release.
Treatment System Impact & Outcomes of Proposition 36 in 5 California Counties
5 R01 DA15431-03 (PI: Hser; Co-PI: Farabee)
07/20/02 - 06/30/06
NIH/NIDA
$3,397,381
The major goal of this project was to examine the treatment system impact and outcomes
of Proposition 36 in five selected counties and to explore the effects of the
implementation of Proposition 36 on California’s treatment delivery system, the system’s
response, and the relationships between the treatment system and the criminal justice
system.
Evaluation of the Mental Health Services Continuum Program (MHSCP)
P02.0016 (PI: Farabee)
7/02 - 6/08
State of California/CDC
$750,000
The major goal of this project was to evaluate the Mental Health Services Continuum
Program (MHSCP) with respect to how well the in-prison and community-based
components were planned, developed, and implemented, and to what extent do activities
and services achieved the program’s goals and objectives.
CDC Prison Treatment Expansion Project: Program Evaluations and Research
Studies
Contract No. 98.346 (PI: Prendergast; Co-PI: Farabee)
7/99-6/04
California Department of Corrections
$3,750,552
The purpose of this project was to conduct process and outcome evaluations of six
prison-based therapeutic community treatment programs funded by the California
Department of Corrections. The project also included examination of special topics
related to prison-based treatment programs that are of interest to the Department.
Substance Abuse, Medication Adherence, and Criminality among Mentally Ill
Parolees
99-CE-VX-0003 (PI: Farabee)
1/00-6/02
National Institute of Justice
$300,000
This study was designed to accomplish five primary goals: (1) assess the rates of
antipsychotic medication adherence among severely mentally ill parolees, (2) validate
the use of hair assays as a means for assessing medication compliance, (3) compare
medication adherence of mentally ill (non-substance dependent) and comorbid parolees,
(4) identify reasons for adherence/non-adherence (according to clinical staff and
parolees), and (5) measure the extent to which medication adherence is associated with
various parolee outcomes such as violent behavior, return to custody, and psychosocial
functioning.
04/28/17
5
Evaluation of the California Youth Authority Residential Substance Abuse
Programs
Contract No. 822-103 (PI: Farabee)
7/98-8/01
California Youth Authority
$426,256
The purpose of the evaluation was to determine the extent to which program components
are being implemented and to identify factors that either impede or enhance the delivery
of program services. Funded by the Office of Criminal Justice Planning, the CYA-RSAT
programs are currently operating at nine institutional sites across the state.
LECTURES & PRESENTATIONS
1992
Lehman, W.E.K., Farabee, D., Holcom, M.L., & Simpson, D.D.
Prediction of substance use: Unique contributions of personal and job
environment factors. Paper presented at the meeting of the Society for
Industrial Organizational Psychologists, Montreal, Canada.
1994
Crouch, B., Dyer, J., Farabee, D., Gorton, J., & Bodiford, C. Field
problems in collecting self-report, urine and hair data on offenders'
substance use. Paper presented at the meeting of the American Society of
Criminology, Miami, FL.
1995
Wallisch, L. and Farabee, D. Gambling and problem gambling among
women in Texas prisons. Paper presented at the meeting of the Ninth
National Conference on Gambling Behavior, San Juan, Puerto Rico.
1995
Farabee, D., McClellan, D., & Crouch, B. Early victimization, drug use,
and criminality: A comparison of male and female prisoners. Poster
session presented at the meeting of the Academy of Criminal Justice
Sciences, Boston, MA.
1996
Leukefeld, C.G. and Farabee, D. Mandatory treatment, HIV, and injecting
drug users. Invited paper presented at the Spanish Interdisciplinary AIDS
Society’s Third National Meeting on AIDS, Galicia, Spain.
1996
Farabee, D. and Leukefeld, C.G. Injection drug use and HIV seropositivity
among incarcerated men and women in the United States. Invited paper
presented at the Spanish Interdisciplinary AIDS Society’s Third National
Meeting on AIDS, Galicia, Spain.
1996
Farabee, D., Leukefeld, C.G., Logan, T., Beaven, S., McKiernan, P.,
Woolley, S., Cavanaugh, B., Clayton, R., Parker, J., Peyton, B., Cantrill,
J., Huffman, M., & McCoy, C. Substance abuse treatment availability by
AIDS-risk severity. Paper presented at the 104th Annual Convention of the
American Psychological Association, Toronto, Canada.
1996
Farabee, D., Leukefeld, C.G., & Logan, T.K. City size, city
seroprevalence, and HIV risk behaviors among out-of-treatment drug
04/28/17
6
users. Paper presented at the National Institute on Drug Abuse
Symposium: Perspectives on Rural Substance Abuse, Ames, IA.
1996
Farabee, D., & McClellan, D.S. Perceptions of punishment: A comparison
of male and female prisoners. Paper presented at the annual meeting of the
Academy of Criminal Justice Sciences, Las Vegas, Nevada.
1997
Farabee, D. Criminal justice treatment: The U.S. experience. Invited paper
presented at the Royal Society of Medicine’s conference “Drug Misusers:
Whose Business is it?” London, England.
1997
Farabee, D., & Leukefeld, C.G. HIV risk among high-frequency arrestees.
Paper presented at the Annual Meeting of the American Society of
Criminology, November 17th, San Diego, California.
1997
Farabee, D., & Leukefeld, C.G. Self-assessed HIV risk and the efficacy of
HIV prevention among street drug users. Poster presented at the 125th
Annual Meeting of the American Public Health Association, Indianopolis,
Indiana.
1997
Farabee, D., & Leukefeld, C.G.
Missed opportunities for AIDS
prevention: Criminal justice and substance abuse treatment settings in a
rural state. Paper presented at the 105th Annual Convention of the
American Psychological Association, Chicago, IL.
1997
Leukefeld, C.G., Farabee, D., Cottler, L., Desmond, D., Hoffman, J.,
Inciardi, J., & Wechsberg, W. A multisite study of real and perceived HIV
risk by county population density. Paper presented at the 59th Annual
Scientific Meeting of the College on Problems of Drug Dependence,
Nashville, TN.
1997
Hays, L., Farabee, D., & Miller, W. Caffeine and nicotine use in an
addicted population. Poster presented at the Conference of the American
Society of Addiction Medicine, San Diego, CA.
1998
Anglin, M.D., & Farabee, D. The role of coercion in offender drug
treatment. Invited paper presented to the Physician Leadership on National
Drug Policy, November 10, Washington, DC.
1998
Farabee, D., Prendergast, M.L., Cartier, J., & Anglin, M.D. Proximal
outcomes from California’s largest in-prison therapeutic community.
Paper presented at the Annual Meeting of the American Society of
Criminology, November 12th, Washington, DC.
1998
Anglin, D.A. & Farabee, D. Coerced treatment of criminal offenders.
Paper presented at the Annual Conference of the American Society of
Addiction Medicine, New Orleans, LA.
2000
Farabee, D. , Prendergast, M.L., & Cartier, J. Psychosocial changes among
special populations in a prison-based therapeutic community. Paper
presented at the Annual Meeting of the American Society of
Criminology, November 15th, San Francisco, CA.
04/28/17
7
2000
Farabee, D., Shen, H., Hser, Y.I., Grella, C., & Anglin, M.D. The effect of
substance abuse treatment on adolescent criminality. Paper presented at
the meeting of the Academy of Criminal Justice Sciences, New Orleans,
LA.
2001
Farabee, D., & Sanchez, S. Substance abuse and medication adherence
among mentally ill parolees. Poster presentation at the Annual Meeting of
the American Psychological Association, August 24-28, 2001, San
Fransico, CA.
2001
Farabee, D., & Sanchez, S. Measuring drug use and medication
adherence among mentally ill parolees. Presented at the Annual
Meeting of the American Society of Criminology, November 7-10,
2001, Atlanta, GA.
2001
Farabee, D., Prendergast, M.L., & Cartier, J. Methamphetamine use and
HIV risk among substance-abusing offenders in california. Poster
presented at the 63rd Annual Scientific Meeting of the College on
Problems of Drug Dependence, Scottsdale, AZ.
2002
Messina, N., Farabee, D., & Rawson, R. Treatment responsivity of
cocaine-dependent patients with antisocial personality disorder.
American Psychological Association, August 25, Chicago, Illinois.
2004
Farabee, D. The effectiveness of needle exchange programs. Invited paper
presented at the Third Meeting of the World Health Organization’s Eastern
Mediterranean Regional Advisory Panel, Cairo, Egypt.
2004
Farabee, D., Hser, Y.I., Anglin, M.D., & Huang, D. Recidivism among an
early cohort of California’s Proposition 36 offenders. Presented at the
Annual Meeting of the American Society of Criminology, November 17,
2004, Nashville, TN.
2005
Farabee, D., & Garner, B. Psychometrics of the Inmate Pre-Release
Assessment (IPASS). Presented at the Annual Meeting of the
American Society of Criminology, November 18, 2004, Toronto, Canada.
2006
Farabee, D. Is Treatment really the road to rehabilitation? Promoting
offender change through accountability. Invited paper presented at the
Semi-Annual Meeting of the National Research Council’s Committee on
Law and Justice. Irvine, CA.
2007
Farabee, D. Evidence-based practices for offenders. Invited paper
presented at the annual meeting of the Oregon District Attorneys’
Association. Bend, OR.
2007
Farabee, D. The Inmate Pre-Release Assessment (IPASS). Presented at the
Annual Meeting of the College on Problems of Drug Dependence, June 20,
2007, Quebec City, Canada.
04/28/17
8
2007
D. Farabee, R. Rawson, M. Karno, V. Pearce, J. Brummer, S. Cousins,
& S. Patel. Four models of telephone support for stimulant recovery.
American Academy of Addiction Psychiatry, San Diego, California, 2007.
2008
Farabee, D. Effective interventions for addicted offenders. Invited
presentation at the Holyrood Magazine conference, “Beyond McLeish:
New Ideas, Lasting Solutions—Seeking Change in Scotland’s Sentencing
Policy.” September 8, 2008. Edinburgh, Scotland.
2008
D. Farabee, R. Rawson, M. Karno, V. Pearce, A. Bellows, J. Hemberg, S.
Cousins, & S. Patel. Continuing care for stimulant recovery: An
experimental test of telephone support. Presented at the Annual Meeting of
the College on Problems of Drug Dependence, June 19, 2008. San Juan,
Puerto Rico.
2009
D. Farabee. HIV and Corrections: An International Perspective. Invited
presentation at the International Conference on Global Health. December
8, 2009. Taipei, Taiwan.
2009
D. Farabee & S. Zhang. Managing an on-the spot lottery in reentry
services. Presented at the Annual Meeting of the American Society of
Criminology, November 18, 2009, Philadelphia, PA.
2010
D. Farabee, Wright, B., & Zhang, S. What is the evidence for evidencebased offender programs? Presented at the Stockholm Criminology
Symposium, June 15, 2010. Stockholm, Sweden.
2010
D. Farabee & S. Zhang. A critical examination of offender needs
assessment: Are all those questions really necessary? Presented at the
Annual Meeting of the American Society of Criminology, November 17,
2010, San Francisco, CA.
2011
D. Farabee, S. Zhang, & B. Wright. Impact of a reentry program on
employment and recidivism: Results of a randomized field experiment.
Presented at the Annual Meeting of the American Society of
Criminology, November 18, 2011, Washington, D.C.
2012
D. Farabee & Zhang, S. Effect-size inflation of post-hoc versus intent-to
treat analyses of experimental offender interventions. Presented at the
Stockholm Criminology Symposium, June 13, 2012. Stockholm, Sweden.
2013
D. Farabee. Global epidemiology of amphetamine-type stimulants. Invited
presentation at the International Conference on Addiction. March 6, 2013.
Jazan, Saudi Arabia.
BIBLIOGRAPHY
Research Papers—Peer Reviewed
1993
04/28/17
Farabee, D., Holcom, M.L., Ramsey, S., & Cole, S. Social anxiety and
speaker gaze in a persuasive atmosphere. Journal of Research in
Personality, 27, 365-376.
9
1993
Farabee, D., Nelson, R., Spence, R. Psychosocial profiles of criminal
justice- and non-criminal justice-referred clients in treatment. Criminal
Justice and Behavior, 20, 336-346.
1995
Farabee, D., Simpson, D.D., Dansereau, D., & Knight, K. Cognitive
inductions into treatment among drug users on probation. Journal of Drug
Issues, 25, 669-682.
1995
Farabee, D., Wallisch, L.S., & Maxwell, J.C. Substance use among Texas
Hispanics and non-Hispanics: Who's using, who's not, and why. Hispanic
Journal of Behavioral Sciences, 17, 523-536.
1995
Lehman, W.E.K, Farabee, D., Holcom, M.L., & Simpson, D.D. Prediction
of substance use in the workplace: Unique contributions of demographic
and work environment variables. Journal of Drug Issues, 25, 253-274.
1996
Farabee, D., & Fredlund, E.V. Self-reported drug use among recently
admitted jail inmates: Estimating prevalence and treatment needs.
Substance Use and Misuse, 31, 423-435.
1997
Leukefeld, C.G, Gallego, M.A., & Farabee, D. Drugs, crime, and HIV.
Substance Use and Misuse, 32(6), 749-756.
1997
Maxwell, J.C., Wallisch, L.S., Farabee D., & Spence, R.T. A model
for assessing prevention needs. Journal of Primary Prevention, 17(3),
315-334 .
1997
McClellan, D., Farabee, D., & Crouch, B. Early victimization, drug use,
and criminality: A comparison of male and female prisoners. Criminal
Justice and Behavior, 24(4), 455-476.
1998
Logan, T.K., Leukefeld, C.G., & Farabee, D. Sexual and drug use
behaviors among women crack users: Implications for prevention. AIDS
Education and Prevention, 10 (4) 327-340.
1998
Farabee, D., Leukefeld, C.G., & Hays, L.R. Accessing drug abuse
treatment: Perceptions of out-of-treatment injectors. Journal of Drug
Issues, 28(2), 381-394.
1998
Farabee, D., Prendergast, M.L., & Anglin, M.D. The effectiveness of
coerced treatment for drug-abusing offenders. Federal Probation, 62, 310.
1998
Hays, L.R., Farabee, D., & Miller, W. Caffeine and nicotine use in an
addicted population. Journal of Addictive Diseases, 17(1), 47-54.
1998
Leukefeld, C.G., Logan, T., Martin, S. Purvis, R.T., & Farabee, D. Health
service utilization among drug -abusing offenders. American Behavioral
Scientist, 41(8), 1122-1135.
1999
Farabee, D., Prendergast, M.L., Cartier, J., Wexler, W., Knight., K., &
Anglin, M.D. Barriers to implementing effective correctional treatment
programs. The Prison Journal, 79(2), 150-162.
04/28/17
10
1999
Farabee, D., & Leukefeld, C.G. Opportunities for AIDS prevention in a
rural state in criminal justice and substance abuse treatment
settings.Substance Use and Misuse, 34 (4&5), 617-632.
1999
Hays, L.R., Farabee, D., & Patel, P. Characteristics of cocaine users in a
private inpatient setting. Journal of Drug Education, 29 (2), 157-164.
1999
Leukefeld, C.G., Logan, T.K., Farabee, D., Watson, D., Spalding, H., &
Purvis, R. Drug dependency and HIV testing among state prisoners.
Population Research and Policy Review, 18, 55-69.
2001
Farabee, D., Joshi, V., & Anglin, M.D. Addiction careers and criminal
specialization. Crime & Delinquency, 47(2), 196-220.
2001
Farabee, D., Shen, H., Hser, Y.I., Grella, C., & Anglin, M.D. The effect of
substance abuse treatment on adolescent criminality. Journal of
Adolescent Research, 16(6), 679-696.
2001
Hegamin, A.H., Anglin, G., & Farabee, D. Gender differences in the
perception of drug treatment: Assessing drug treatment for youthful
offenders. Substance Use and Misuse, 36, 2159-2170.
2001
Prendergast, M.L., Farabee, D., & Cartier, J. The impact of in-prison
therapeutic community programs on prison management. Journal of
Offender Rehabilitation, 32(3), 63-78.
2002
Burdon, W.M., Farabee, D., Prendergast, M.L., Messina, N.P., & Cartier,
J. Prison-based therapeutic community programs: Implementation and
operational issues. Federal Probation, 66(3), 3-8.
2002
Farabee, D. Editor of special issue: Making people change: The
effectiveness of coerced psychological treatment. Criminal Justice and
Behavior, 29(1).
2002
Farabee, D. Re-examining Martinson’s critique: A cautionary note for
evaluators. Crime & Delinquency, 48(1), 189-192.
2002
Farabee, D., Prendergast, M.L., & Cartier, J. Methamphetamine use and
HIV risk among substance-abusing offenders in California. Journal of
Psychoactive Drugs, 34(3), 295-300. (PMID: 12422940)
2002
Farabee, D., Rawson, R.A., & McCann, M. Adoption of drug
avoidance activities among patients in contingency management and
cognitive-behavioral treatments. Journal of Substance Abuse Treatment,
23, 343-350. (PMID: 12495796)
2002
Farabee, D., Shen, H., & Sanchez, S. Perceived coercion and treatment
need among mentally ill parolees. Criminal Justice and Behavior, 29(1),
76-86.
2002
Leukefeld CG, Logan TK, Farabee D, Clayton R., Drug use and AIDS:
estimating injection prevalence in a rural state. Subst Use Misuse. 2002,
37(5-7), 767-782. (PMID: 12117069)
04/28/17
11
2002
Leukefeld, C.G., Farabee, D., McDermeit, M., Dennis, M.L., Wechsberg,
W.M., Inciardi, J.A., Surratt, H.L., Compton, W.M., Cottler, L.B., Klein,
H., Hoffman, J.A., Desmond, D., & Logan, T.K. Real and perceived HIV
risk by population density. Journal of Drug Issues, 31(4), 889-900.
2002
Prendergast, M.L., Farabee, D., Cartier, J., & Henken, S. Coerced
treatment within a prison setting: Impact on psychosocial change during
treatment. Criminal Justice & Behavior, 29 (1), 5-26.
2002
Rawson, R.A, Huber, A., McCann, M., Shoptaw, S., Farabee, D., Reiber,
C., & Ling, W. A comparison of contingency management and cognitivebehavioral approaches during methadone maintenance treatment for
cocaine dependence. Archives of General Psychiatry, 59, 817-824. (PMID:
12215081)
2003
Hegamin, A., & Farabee, D. RSAT programs for youngh offenders in
California: A Descriptive Study. Journal of Offender Rehabilitation, 37,
123-138.
2003
Hser, Y.I., Teruya, C., Evans, E., Longshore, D., Grella, C., & Farabee, D.
Treating drug-abusing offenders: Initial findings from a five-county study
on the impact of California’s Proposition 36 on treatment system and
patient outcomes. Evaluation Review, 27 (5),479-505. (PMID:14531316)
2003
Messina, N., Farabee, D., & Rawson, R. Treatment responsivity of
cocaine-dependent patients with antisocial personality disorder in
cognitive behavioral and contingency management interventions. Journal
of Consulting and Clinical Psychology, 71(2), 320-329. (PMID:
12699026)
2004
Farabee, D., Hser, Y.H., Anglin, M.D., & Huang, D. Recidivism among an
early cohort of California’s Proposition 36 offenders. Criminology &
Public Policy, 3(4), 501-522.
2004
Farabee, D., Shen, H., & Sanchez, S. Program-level predictors of
antipsychotic medication adherence among parolees. International
Journal of Offender Therapy and Comparative Criminology, 48(5), 561571. (PMID: 15358931)
2004
Farabee, D., & Shen, H. Antipsychotic medication adherence, cocaine use,
and recidivism among a parolee sample.Behavioral Sciences and the Law,
22, 467-476. (PMID: 15282835)
2004
Prendergast, M.L., Campos, M., Farabee, D., Evans, W., & Martinez, J.
Reducing substance use in prison: The California Department of
Corrections Drug Reduction Strategy Project. The Prison Journal, 84 (2),
265-280.
2006
Cartier, J., Farabee, D., & Prendergast, M.L. Methamphetamine use,
violence, and recidivism among California parolees. Journal of
Interpersonal Violence, 21, 435-445. (PMID: 16501213)
04/28/17
12
2007
Farabee, D., Knight, K., Garner, B., & Calhoun, S. The Inmate Pre-Release
Assessment (IPASS) for re-entry planning. Criminal Justice & Behavior,
34(9), 1188-1197.
2007
Burdon, W.M., Dang, J., Prendergast, M. L., Messina, N.P., & Farabee, D.
Differential effectiveness of residential versus outpatient aftercare for
parolees from prison-based therapeutic community treatment programs.
Substance Abuse Treatment, Prevention, and Policy, 2:16. (PMID:
17504540) (PMCID: PMC1884138)
2007
Grella, C.E., Greenwell, L., Prendergast, M.L., Farabee, D., Hall, E.,
Cartier, J., & Burdon, W. Organizational characteristics of drug abuse
treatment programs for offenders. Journal of Substance Abuse Treatment,
32, 291-300. (PMID: 17383553) (PMCID: PMC1941644)
2009
Prendergast, M., Greenwell, L., Farabee, D., Hser, Y.I.., Influence of
perceived coercion and motivation on treatment completion and re-arrest
among substance-abusing offenders. J Behav Health Serv Res., 36(2), 15976. (PMID: 18516684)
2010
Peng, E.Y., Lee, M., Morisky, D.E., Yeh, C.Y., Farabee, D., Lan, Y.C.,
Chen, Y.M.A., Lyu, S.Y. Psychiatric morbidity in HIV-infected male
prisoners. Journal of the Formosan Medical Association, 109 (3), 177-184.
2010
Peng E.Y., Yeh C.Y., Lyu S.Y., Morisky D.E., Chen Y.M., Lee M.B.,
Farabee D., & Malow R. Prevalence and correlates of lifetime suicidal
ideation among HIV-infected male inmates in Taiwan. AIDS Care, 10,
1212-1220. PMID: 20845113
2011
Farabee, D., Hawken, A., & Griffith, P. Tracking and incentivizing
substance abusers in longitudinal research: Results of a survey of NIDAfunded investigators. Journal of Addiction Medicine, 5(2), 87-91.
[PMC3140135]
2011
Farabee, D., Zhang, S.X., & Yang, J. A preliminary examination of
offender needs assessment: Are all those questions really necessary?
Journal of Psychoactive Drugs, 43, 1-7.
2012
Farabee, D. Zhang, S.X., & Wright, B. Managing an on-the-spot lottery in
re-entry services. Journal of Experimental Criminology, 8,241–253.
2012
Karno, M., Farabee, D., Brecht, M.L., & Rawson, R.A. Patient reactance
moderates the effect of directive telephone counseling for
methamphetamine users. Journal of Studies on Alcohol and Drugs, 73,
844–850.
2012
Ling, W., Farabee, D., Liepa, D., & Wu, L. T. The Treatment
Effectiveness Assessment (TEA): an efficient, patient-centered instrument
for evaluating progress in recovery from addiction. Substance Abuse, 3,
129-136.
04/28/17
13
2012
Wright, B., Zhang, S.X., & Farabee, D. A squandered opportunity: A
review of SAMHSA’s National Registry of Evidence-based Programs and
Practices (NREPP) for offenders. Crime & Delinquency, 6, 954 – 972.
2013
Farabee, D, Cousins, S.J., Brecht, M.L., Antonini, V.P., Lee, A.B.,
Brummer, J., Hemberg, J., Karno, M., & Rawson, R.A. A Comparison of
four telephone-based counseling styles for recovering stimulant users.
Psychology of Addictive Behavior, 27.1, 223. (PMCID: PMC3500433,
NIHMSID: NIHMS396172)
2013
Farabee, D., McCann, M., Brecht, M.L., Cousins, S.J., Antonini, V.P.,
Lee, A.B., Brummer, J., Hemberg, J., Karno, M. & Rawson, R.A. An
analysis of relapse prevention factors and their ability to predict sustained
abstinence following treatment completion. American Journal of
Addictions, 22(3), 206-211.
2014
Farabee, D., Zhang, S.X., & Wright, B. An experimental evaluation of a
nationally recognized employment-focused offender reentry program.
Journal of Experimental Criminology, 1-14.
2014
Lyu, S.Y., Chi.,Y.C., Farabee,. D., Tsai, L.T., Lee, M.B., Lo, F.E., &
Morisky, D.E. Psychological distress in an incarcerated juvenile
population. Journal of the Formosan Medical Association.
2014
Wright, B., Zhang, S.X., & Farabee, D. Prisoner reentry research from
2000-2010: Results of a narrative review. Criminal Justice Review, 39(1),
37-57.
2014
Zhang, S.X., Roberts, R., and Farabee, D. An analysis of prisoner reentry
and parole risk using COMPAS and traditional criminal history measures.
Crime & Delinquency, 60(2), 167-192.
In press
Farabee, D., Calhoun, S., & Veliz, R. An experimental comparison of
telepsychiatry and onsite psychiatry for parolees. Psychiatric Services.
Research Papers—Non-Peer Reviewed
1998
Lehman, W.E.K., Farabee, D, & Bennett, J.B. Perceptions and correlates
of coworker substance abuse. Employee Assistance Quarterly, 13(4), 1-22.
2006
Farabee, D. An evaluation of California’s Mental Health Services
Continumm Program for parolees. Corrections Today, 68(7), 38-41.
2015
Farabee, D. Book Review: The methamphetamine industry in America:
Transnational cartels and local entrepreneurs. Criminal Justice Review,
0734016815573305.
Chapters
04/28/17
14
2001
Farabee, D. and Leukefeld, C.G. Recovery and the criminal justice system.
In J.J. Platt, F.M. Tims, and C.G. Leukefeld (Eds.) Relapse and Recovery
Processes in the Addictions, pp. 40-59. New Haven, CT: Yale University
2002
Farabee, D. & Leukefeld, C.G. HIV/AIDS in the criminal justice system.
In C.G. Leukefeld, F. Tims, and D. Farabee (Eds.) Treatment of Drug
Offenders: Policies and Issues, pp. 172-185. New York: Springer.
2004
Farabee. D., Shen, H., Prendergast, M.L, & Cartier, J. The effectiveness of
coerced admission into prison-based drug treatment. In K. Knight and D.
Farabee (Eds.), Treating Addicted Offenders: A Continuum of
Opportunities, pp. 31:1-12. New York: Civic Research Institute.
2004
Longshore, D., Prendergast, M., & Farabee, D. Coerced treatment for
drug-using criminal offenders. In P. Bean (Ed.), Drug Treatment: What
Works?, pp. 110-122. London: Taylor & Francis Books.
2005
Satel, S., & Farabee, D. The role of coercion in drug treatment. In J.H.
Lowinson, P. Ruiz, R.B. Millman, & J.G. Langrod (Eds.) Substance
Abuse: A Comprehensive Textbook, pp. 690-707. New York: Lippincott
Williams & Wilkins.
2006
Messina, N., Farabee, D., & Rawson, R. Cocaine-dependent patients with
antisocial personality disorder (Chapter 5). In F. Columbus (Ed.) Cocaine
Abuse: New Research. Hauppauge, NY: Nova Science Publishers, Inc.
2007
Farabee, D. Monitoring drug use and medication adherence among
mentally ill parolees. In K. Knight and D. Farabee (Eds.), Treating
Addicted Offenders: A Continuum of Opportunities, Vol. II, pp. 20:1-3.
New York: Civic Research Institute.
2009
Farabee, D., & Hawken, A. Methamphetamine and crime. In J. M. Roll, R.
Rawson, W. Ling, & S. Shoptaw (Eds.). Methamphetamine
Addiction. pp. 157-151. New York: Guilford.
2015
Farabee, D., Rawson, R.A., & Gawad, T. Treatment in the criminal justice
system. In Nady El-Guebaly, Marc Galanter and Giuseppe Carrá (Eds),
Textbook of Addiction Treatment: International Perspectives. Heidelberg,
Germany: Springer.
Editorials
2002
Farabee, D. Addicted to treatment: Ideology is trumping science in our
quest to rehabilitate offenders. Forbes, December 23. p.60.
2002
Farabee, D., Prendergast, M.L., & Cartier, J. Alcohol, the “un-drug.”
Psychiatric Services, 53 (11), 1375-1376. (PMID: 12407261)
2006
Farabee, D. Why the expansion of offender programs is premature.
Journal of Community Corrections, 16(1), 9-10.
04/28/17
15
2006
Farabee, D. Reinventing criminal justice. Washington Post, February 11, .
p A19.
2006
Farabee, D. Naltrexone as negative reinforcement: Comments on "A
behavioral analysis of coercion in substance abuse treatment." Journal of
Substance Abuse Treatment, 31(2), 141-142. (PMID: 17504540)
2007
Farabee, D. For the Second Chance Act of 2007, great strides will come in
small steps. Federal Sentencing Reporter, 20 (2), 136-137.
Books
2002
Leukefeld, C.G., Tims, D., & Farabee, D. (Eds.) Treatment of Drug
Offenders: Policies and Issues.New York: Springer.
2004
Knight, K. & Farabee, D. (Eds.), Treating Addicted Offenders: A
Continuum of Opportunities. New York: Civic Research Institute.
2005
Farabee, D. Rethinking Rehabilitation: Why Can’t We Reform Our
Criminals? Washington, DC: AEI Press.
2007
Knight, K. & Farabee, D. (Eds.), Treating Addicted Offenders: A
Continuum of Opportunities, Vol II. New York: Civic Research Institute.
04/28/17
16